EW Operating Income Growth
Edwards Lifesciences · Operating Income Growth
EW Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported22.88%period ending
EW TTM Operating Income YoY % (-47.75% → 22.88%)
Year-over-year change
High-resolution chart · PNG
EW operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 22.8827% | |
| 22.373% | |
| 17.1823% | |
| 9.5201% | |
| 4.6017% | |
| -0.4618% | |
| -6.3118% | |
| -6.6627% | |
| -11.5956% | |
| -14.3054% | |
| -13.182% | |
| -7.4829% | |
| -1.4084% | |
| 0.7612% | |
| 5.6135% | |
| 2.6197% | |
| 5.0428% | |
| 24.9% | |
| 24.2593% | |
| 26.7627% | |
| 28.8817% | |
| 5.5343% | |
| 8.3703% | |
| 10.6101% | |
| 7.9173% | |
| 11.2016% | |
| 9.4846% | |
| 10.0901% | |
| 11.0912% | |
| 15.376% | |
| 6.8996% | |
| 5.4887% | |
| 3.7213% | |
| 9.2533% | |
| 29.309% | |
| 30.8598% | |
| 36.0589% | |
| 31.9052% | |
| 22.9501% | |
| 24.2808% | |
| 22.5086% | |
| 22.4887% | |
| 33.1745% | |
| 31.184% | |
| 33.6395% | |
| 26.4538% | |
| 6.1826% | |
| -0.2796% | |
| -4.9749% | |
| 1.5516% | |
| 11.288% | |
| 28.0992% | |
| 39.5979% | |
| 40.2859% | |
| 36.088% | |
| 23.3855% | |
| 8.8167% | |
| 2.6% | |
| 5.5575% | |
| 9.7352% | |
| 17.3473% | |
| 21.9512% | |
| 19.4538% | |
| 17.3304% | |
| 18.8078% | |
| 19.0707% | |
| 27.5456% | |
| 29.0232% | |
| 27.745% | |
| 26.1294% | |
| 7.4266% | |
| 3.3256% | |
| -3.2% | |
| -5.6452% | |
| -10.9231% | |
| -13.9126% | |
| -12.0603% | |
| -12.8951% | |
| 10.8584% | |
| 18.1602% | |
| 21.5638% | |
| 25.9798% | |
| 26.5468% | |
| 21.8366% | |
| 21.3491% | |
| 26.0558% | |
| 2.8868% | |
| 8.8976% | |
| 148.893% | |
| 131.5498% | |
| 159.309% | |
| 164.0333% | |
| -51.7364% | |
| 94.2652% | |
| 117.0833% | |
| 11.8605% | |
| 155.2273% | |
| -73.5043% | |
| -76.7667% | |
| -47.7521% |